Florida Blue Spravato Reimbursement Rates in Florida (2026)

Florida Blue pays a median of $1,100.21 for an 84 mg Spravato session (G2083), but the drug alone costs about $1,290. For 68 of the 70 Florida prescribers in its files, buying the drug and billing this code loses money on every 84 mg dose.

These rates come from Florida Blue’s July 2026 files for its own Florida networks, 138 gigabytes of pricing data. They cover its BlueOptions, BlueCare and BlueChoice networks, which carry most of its employer plans. Several individual exchange plans, including BlueSelect and myBlue plans, use four other network files that we could not download, so they are not included.

Florida Blue’s Negotiated Spravato Rates in Florida

We kept dollar rates on professional claims in the office setting, since in a facility the drug is paid on the facility’s claim. We matched each NPI to the federal NPPES registry and kept psychiatrists and psychiatric nurse practitioners who practice in Florida. That leaves 70 prescribers, a small group, because Florida Blue’s files list far fewer individual clinicians than other Blue plans’ files do.

Rates from Florida Blue’s July 2026 Florida machine readable files for the networks named above.

G2082 and G2083 pay for the visit, the drug and two hours of observation in one payment. J0013 pays for the drug alone, per milligram.

Does Florida Blue’s Spravato Rate Cover What You Pay for the Drug?

Almost never for 84 mg, and usually not for 56 mg. Pharmacies paid about $426 to $430 per 28 mg device as of October 7, 2026, according to the federal NADAC pharmacy price survey. That puts an 84 mg dose, three devices, at about $1,290 and a 56 mg dose, two devices, at about $853.

• 84 mg sessions (G2083). The most common rate, $1,038.97, falls about $251 short of the drug. The median falls about $190 short. Only 2 of the 70 prescribers have a rate that covers the drug, and the highest is $1,343.49.
• 56 mg sessions (G2082). The median falls about $79 short of the drug. 56 of the 70 prescribers have no rate that covers it.

Those gaps come before anything is paid for the visit or the two hours of observation. Run your own numbers with your contracted rates and drug cost:

Can You Bill Florida Blue for Spravato With J0013 Instead of G2083?

We found no Florida Blue rule that answers this, so ask in writing before you rely on it. Its Spravato coverage guideline lists G2082, G2083 and J0013 as the codes that describe the service. Its reimbursement section adds nothing on which to bill. We found no other Florida Blue billing guidance for Spravato as of October 8, 2026.

The files make the question worth asking. Florida Blue lists a J0013 rate of $16.30 per milligram for 69 of the 70 prescribers. At that rate, an 84 mg dose pays $1,369.20, about $79 more than the drug costs. The visit and observation would then be billed separately. Whether a claim billed that way pays depends on your contract.

Should Florida Practices Use a Specialty Pharmacy for Spravato?

For 84 mg patients on almost every contract in the files, yes. Florida Blue’s specialty drug lists, current October 1, 2026, cover Spravato either as a self-administered or as a provider-administered specialty drug. Both routes need prior authorization, and only certain specialty pharmacies dispense it. When a pharmacy supplies the drug, the pharmacy bills Florida Blue for it, so confirm with Florida Blue which codes your practice bills for the visit and observation.

Plan the induction month before you choose the pharmacy route. Florida Blue’s October 2026 medication guides set a quantity limit of 4 dose packs per 28 days. Florida Blue’s guideline allows 84 mg twice a week for the first four weeks, which is 8 sessions. So ask whether your patient’s approval lifts the limit, or the pharmacy may supply only half the induction doses.

Buying the drug makes sense only if your G2083 rate is well above about $1,290, or if Florida Blue confirms in writing that you can bill J0013. Our Blue Cross and Blue Shield of Texas Spravato rates page shows how another Blue plan prices the same codes.

What Does Florida Blue Require Before Approving Spravato?

Florida Blue requires two failed antidepressants from different classes plus a third step. Its guideline was last revised April 15, 2026. For treatment-resistant depression, the request needs:

• A baseline score. A rating scale taken in the past 30 days while on antidepressants, such as a PHQ-9 of 15 or more or a MADRS of 28 or more.
• Two antidepressant trials. Two drugs from different classes, each for at least six weeks at an adequate dose, in the current episode.
• An add-on or therapy. One of those drugs used with an add-on drug such as lithium or an atypical antipsychotic, or with evidence-based psychotherapy such as CBT. The psychotherapy option was added in the April 2026 revision.
• A psychiatrist involved. The drug must be prescribed by, or in consultation with, a psychiatrist.

The first approval lasts four months, enough for 12 weeks of treatment. Renewals last six months and need a baseline score plus two follow-up scores showing more than 50 percent improvement. After that, dosing is capped at 84 mg once a week.

The guideline lists recurrent depression codes (F33.0 to F33.9) and suicidal ideation (R45.851) as the diagnoses that support coverage. It does not list single-episode codes (F32), so check with Florida Blue before treating a patient in a first episode.

How Does Florida’s Step Therapy Law Apply to Spravato?

Florida’s law gives two protections but does not limit how many drugs a plan can require. Section 627.42393 covers insurers, and section 641.31(46) sets the same rules for HMOs such as BlueCare:

• Carryover from another plan. A patient approved for the drug through another plan’s step therapy does not repeat it, if they show the other plan paid for the drug in the previous 90 days.
• An exemption process. The plan must publish a way to request an exemption, decide within a reasonable time, and explain any denial with its clinical reasons and appeal steps.

Florida Blue’s guideline points to its exemption process and cites the law. The law covers plans Florida regulates, not employer plans that pay their own claims. Florida Blue’s renewal criteria also accept a Spravato approval from another plan in the past 12 months, which helps patients who switch to Florida Blue mid-treatment.

What This Means for Your Practice

Read these numbers with care. They describe 70 prescribers in Florida Blue’s group network files from July 2026, not its individual exchange plans. Even so, the pattern is consistent. On nearly every contract in the files, the bundled 84 mg rate does not cover the drug.

Check your own Florida Blue rates before choosing how to supply the drug:

• Compare G2083 with your drug cost. If your rate is below what you pay for an 84 mg dose, buy-and-bill loses money on those sessions.
• Ask about J0013 in writing. If Florida Blue allows it on your contract, the drug code pays more than the drug costs at the median.
• Plan the induction month. Confirm whether the approval lifts the pharmacy quantity limit before the first dose.

Our guide to negotiating insurance contract rates covers how to ask for a better bundled rate. Our Florida Blue behavioral health rates page covers the therapy codes.

Once good rates are in place, Fuse helps make sure you actually get paid them. We check claims against your contracted rates and flag the gap between contracted and paid before it grows. Reach out if you’d like to chat.

Disclaimer: This article uses rate information from the Machine Readable Files that Florida Blue publishes under the federal Transparency in Coverage rule. These files are posted to satisfy the regulation, not to be read. The files behind this analysis unpack to 138 gigabytes of raw pricing data that no spreadsheet can open. Fuse built its own software to extract and verify the figures above. Drug costs are national pharmacy averages and your own acquisition cost may differ. This analysis focuses on a single payer and its group network files, and will not reflect rates from all available insurance options in Florida. Fuse makes every effort to provide accurate and current information, but healthcare pricing and coverage policy change frequently, and individual circumstances affect actual payment. This information does not guarantee specific pricing. Practices should verify current rates and criteria directly with Florida Blue before relying on them for billing or negotiation decisions.